ONC Share Price

Open 0.63 Change Price %
High 0.63 1 Day 0.00 0.00
Low 0.60 1 Week -0.02 -3.23
Close 0.60 1 Month 0.24 66.67
Volume 139165 1 Year 0.16 36.36
52 Week High 0.75
52 Week Low 0.19
ONC Important Levels
Resistance 2 0.63
Resistance 1 0.62
Pivot 0.61
Support 1 0.58
Support 2 0.57
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
MFC 23.39 -0.04%
MFC 23.39 -0.04%
MFC 23.39 -0.04%
MFC 23.39 -0.04%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
AVP 0.08 14.29%
AVP 0.08 14.29%
AVP 0.08 14.29%
AVP 0.08 14.29%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
TLB 3.73 -13.26%
TLB 3.73 -13.26%
BNG 0.15 -11.76%
BNG 0.15 -11.76%
NKO 0.08 -11.11%
NKO 0.08 -11.11%
NKO 0.08 -11.11%
CTU-A 0.19 -9.52%
HRX 11.52 -9.29%
More..

Oncolytics Biotech Inc (TSE: ONC)

ONC Technical Analysis 4
As on 27th Mar 2017 ONC Share Price closed @ 0.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.40 & Strong Buy for SHORT-TERM with Stoploss of 0.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
ONC Target for March
1st Target up-side 0.44
2nd Target up-side 0.49
3rd Target up-side 0.54
1st Target down-side 0.28
2nd Target down-side 0.23
3rd Target down-side 0.18
ONC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.oncolyticsbiotech.com
ONC Address
ONC
1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7
Canada
Phone: 403-670-7377
Fax: 403-283-0858
ONC Latest News
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration with Myeloma ...   Canada NewsWire (press release)   - 16th Mar 17
Oncolytics Biotech® Inc. Announces Management Team Changes   Canada NewsWire (press release)   - 03rd Nov 16
Reviewing Individual Broker Targets Of Oncolytics Biotech, Inc. (ONCY)   NewsDen   - 05th Jun 16
Where Can Oncolytics Go After Dismal ASCO Results?   Seeking Alpha   - 20th May 16
Oncolytics Biotech® Inc. Reports Preliminary Data from Randomized Phase II ...   PR Newswire (press release)   - 19th May 16
GOG Sends Rebuttal Letter to Oncolytics Biotech   The Cancer Letter Publications   - 03rd May 16
Oncolytics: Killing Cancer With A Virus   Seeking Alpha   - 20th Jul 15
Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Extension ...   Smarter Analyst   - 29th Apr 15
On the Reversal: Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY)   MicroCap Daily   - 10th Feb 15
Oncolytics Biotech: What Is All The Excitement About?   Seeking Alpha   - 18th Dec 12
Interactive Technical Analysis Chart Oncolytics Biotech Inc ( ONC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oncolytics Biotech Inc
ONC Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.